Alexis Boaz brings her analytical skills and client-focused approach to represent and advise a diverse group of health care clients, including health plans, clinical laboratories, pharmaceutical companies, pharmacy benefit managers, pharmacy chains, telehealth providers, medical device companies, providers and provider groups, hospitals and health systems, management services organizations, trade associations, and other clients.
Alexis focuses her work on regulatory due diligence, regulatory counseling, and policy and legislative analysis. She walks clients through:
- compliance with the No Surprises Act and state surprise and balance billing laws, particularly on matters impacting providers, facilities, and clinical laboratories;
- all health regulatory aspects of mergers, acquisitions, other health care transactions;
- state health care regulatory issues associated with change of ownership and Medicaid provider enrollment;
- health licensing issues for providers and facilities, including telehealth providers;
- legal and regulatory matters arising under Medicare, Medicaid and other third-party reimbursement programs, including coding, coverage, and payment;
- government inquiries and investigations;
- state and federal health care fraud and abuse laws and regulations; and
- regulatory analysis and advocacy for trade groups and other clients.
She also closely follows developments to keep clients up to date on surprise billing and prescription drug pricing matters, the individual marketplace, and developments in Medicare.
Clients know Alexis understands how legislative and regulatory changes affect health industry trends. Alexis’ prior experience across the public and private sectors and her in-depth knowledge of health policy and regulatory matters make her exceptionally qualified to navigate clients through the complexities of the health care regulatory landscape at the state and federal level. That experience includes interning in the U.S. Department of Health and Human Services in:
- the Office of General Counsel’s Centers for Medicare & Medicaid Services Division where she analyzed care models proposed by the Center for Medicare & Medicaid Innovation;
- the Office of Global Affairs’ Division for Trade and Health where she analyzed prescription drug pricing issues;
- the Office of General Counsel’s Public Health Division; and
- the Office of Inspector General’s Office of Evaluations and Inspections.
She also served as:
- a Health Policy Law Clerk for the U.S. Senate Committee on Finance;
- a Health Policy Fellow for the Congressional Black Caucus Foundation Health Braintrust in the U.S. House of Representatives; and
- a Health Policy Intern for the U.S. Senate Committee on Health, Education, Labor & Pensions.
She was also a Legal Intern in the Executive Office of the President during the Obama Administration. She has gained further exposure to other aspects of the health care industry through her work at a public policy think-tank; a nonprofit, academic health system in Tennessee; the Washington, D.C., Department of Health; an academic teaching hospital in Washington; and a national nonprofit public health charitable organization focused on fetal alcohol syndrome. Alexis co-leads Epstein Becker Green’s (“EBG’s”) “100 Days Focused Initiative” where she tracks and analyzes notable legislative, policy, and regulatory developments under the Biden Administration to help clients anticipate trends in health care. She is a contributing author of EBG’s Telemental Health Laws app, a comprehensive survey of state telehealth laws, regulations, and policies for mental and behavioral health practitioners and stakeholders across all 50 states, the District of Columbia, and Puerto Rico. She also contributes to the firm’s Health Law Advisor Blog and co-authors client alerts on new developments in health law and policy.